Consolidated Condensed Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2015	Oct. 31, 2014
Capital Expenditures Incurred but Not yet Paid	$ 24,631	$ 10,419
Non-cash capital expenditures under long-term financing	0	9,492
Cash flows from operating activities:
Net income (loss)	(59,670)	(64,324)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	38,700	35,969
Cost of real estate sales	6,940	7,015
Stock-based compensation expense	4,090	4,201
Deferred income taxes, net	(36,574)	(37,777)
Change in Fair Value of Contingent Consideration	0	(4,550)
Gain (Loss) Related to Litigation Settlement	0	(16,400)
Park City litigation payment to Talisker	0	(10,000)
Other non-cash income, net	(1,862)	(1,614)
Increase (Decrease) in Restricted Cash	(7,450)	104
Changes in assets and liabilities:
Trade receivables, net	62,174	61,016
Inventories, net	(21,612)	(20,733)
Accounts payable and accrued liabilities	83,805	81,156
Other assets and liabilities, net	(8,870)	(9,376)
Net cash provided by operating activities	74,571	24,479
Cash flows from investing activities:
Capital expenditures	(25,077)	(27,756)
Acquisition of businesses	0	(182,500)
Other investing activities, net	3,023	629
Net cash used in investing activities	(22,054)	(209,627)
Proceeds from Issuance of Other Long-term Debt	70,000	213,000
Line of Credit Facility, Periodic Payment	57,500	30,000
Repayments of Long-term Debt	(253)	(253)
Cash flows from financing activities:
Dividends paid	(22,654)	(15,061)
Payments for Repurchase of Common Stock	(40,000)	0
Other financing activities, net	2,829	2,912
Net cash used in financing activities	(47,578)	170,598
Effect of exchange rate changes on cash and cash equivalents	(792)	(16)
Net decrease in cash and cash equivalents	4,147	(14,566)
Cash and cash equivalents:
Beginning of period	35,459	44,406
End of period	$ 39,606	$ 29,840